Money Australia - August 2019

(Barré) #1

This publication is dated July 2019, is given in good faith and is derived from sources believed to be accurate as at this date, which may be subject to
change. It should not be considered to be a comprehensive statement on any matter and should not be relied on as such. It does not take into account
the personal objectives, financial situation or needs of any person. You should consider these factors, the appropriateness of the information, and
the relevant fund’s Product Disclosure Statement (available from your adviser or at before making any decisions. Past performance
is not a reliable indicator of future performance. The funds are issued by Zurich Investment Management Limited ABN 56 063 278 400 AFSL 232511.
GINN: FVHHKJ.00012.ME.036. DFOY-014563-




For investors who want to do some good while
generating growth opportunities in their
portfolio, Zurich Investments Global Growth
strategy is a unique opportunity to make a
difference to the future of millions of people –
including those they care about most.

Our strategic partnership with American
Century Investments enables you to help fund
important medical research for
life-threatening diseases such as cancer,
diabetes and dementia.

From finding a cure for cancer to discovering
the genetic triggers for Alzheimer’s, these
big challenges demand a different approach
to research funding. Since 2000, American
Century Investments’ distinctive ownership
structure has already provided more than
$1.5 billion to the Stowers Institute for
Medical Research – while also providing
growth opportunities for investors.

Find out more about investing
for the greater good.

CALL 1800 004 480

Free download pdf